美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA210221"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
71335-2877-1 71335-2877 HUMAN PRESCRIPTION DRUG Cephalexin Cephalexin FOR SUSPENSION ORAL 20251107 N/A ANDA ANDA210221 Bryant Ranch Prepack CEPHALEXIN 250 mg/5mL 200 mL in 1 BOTTLE (71335-2877-1)
71335-2986-1 71335-2986 HUMAN PRESCRIPTION DRUG Cephalexin Cephalexin FOR SUSPENSION ORAL 20251110 N/A ANDA ANDA210221 Bryant Ranch Prepack CEPHALEXIN 250 mg/5mL 100 mL in 1 BOTTLE (71335-2986-1)
68071-5038-0 68071-5038 HUMAN PRESCRIPTION DRUG Cephalexin Cephalexin FOR SUSPENSION ORAL 20190821 N/A ANDA ANDA210221 NuCare Pharmaceuticals,Inc. CEPHALEXIN 250 mg/5mL 100 mL in 1 BOTTLE (68071-5038-0)
67877-544-68 67877-544 HUMAN PRESCRIPTION DRUG Cephalexin Cephalexin FOR SUSPENSION ORAL 20190328 N/A ANDA ANDA210221 Ascend Laboratories, LLC CEPHALEXIN 125 mg/5mL 200 mL in 1 BOTTLE (67877-544-68)
67877-544-88 67877-544 HUMAN PRESCRIPTION DRUG Cephalexin Cephalexin FOR SUSPENSION ORAL 20190328 N/A ANDA ANDA210221 Ascend Laboratories, LLC CEPHALEXIN 125 mg/5mL 100 mL in 1 BOTTLE (67877-544-88)
67877-545-68 67877-545 HUMAN PRESCRIPTION DRUG Cephalexin Cephalexin FOR SUSPENSION ORAL 20190328 N/A ANDA ANDA210221 Ascend Laboratories, LLC CEPHALEXIN 250 mg/5mL 200 mL in 1 BOTTLE (67877-545-68)
67877-545-88 67877-545 HUMAN PRESCRIPTION DRUG Cephalexin Cephalexin FOR SUSPENSION ORAL 20190328 N/A ANDA ANDA210221 Ascend Laboratories, LLC CEPHALEXIN 250 mg/5mL 100 mL in 1 BOTTLE (67877-545-88)
50090-4795-0 50090-4795 HUMAN PRESCRIPTION DRUG Cephalexin Cephalexin FOR SUSPENSION ORAL 20191212 N/A ANDA ANDA210221 A-S Medication Solutions CEPHALEXIN 250 mg/5mL 200 mL in 1 BOTTLE (50090-4795-0)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2026 Drugfuture->U.S. FDA National Drug Code DataBase